Tadej Pogačar in the Giro D’Italia TT 2024 in Foligno  Source: Blue Ice Publishing

The leader of the Giro d’Italia wears the iconic pink jersey or Magli Rosa.

Not only is it appropriate for cancer research, but we think a long distance cycle race has a lot in common with cancer research – think about racing in stages, in a dynamic environment, and overcoming adverse conditions.

In this post we take a closer look at an aptly named company Bicycle Therapeutics through the lens of an interview with their CEO, Dr Kevin Lee.

We also take a closer look at the science and what strategic opportunities their novel designs may offer.

Will their Bicycle Toxin Conjugates and Bicycle Radio Conjugates take the cancer new product development to new heights and end up being the “race” leader?

To learn more from our latest oncology review and get a heads up on key cancer research insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by